chrisvoncsefalvay/vaers-outcomes huggingface dataset:
From initial information received on 06/16/04 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 33 year old male pt with a history of asthma and eczema received an IPOL vaccination, Lot # X0772, administered SC in the upper right arm, a MENOMUNE A/C/Y/W-135 vaccination, Lot # UE111AA, administered SC in the lower left deltoid and a TWINRIX vaccination, Lot # AKE239A4, administered IM in the left deltoid on 01/09/04.  At the time of vaccination the pt was also taking albuterol, singulair and flovent.  Four days post-immunization, 06/13/04, the pt developed a fever, flu-like symptoms and a rash on his upper torso.  Three days later, 06/16/04, the pt developed swollen gums. He was evaluated that same day by a physician and Benadryl 25mg per oral every 4 hours was prescribed as treatment.  The pt is to be re-evaluated by the physician on 06/17/04.  It was not reported whether the pt recovered from these events. Previously the pt had received his first dose of YF-Vax vaccine, Lot # UE128AA, administered SC in the right upper arm, his first dose of Typhim VI vaccine, Lot # X0521, administered in the right deltoid and a booster dose of TD ADULT, Lot # U1024AA, admnistered IM in the left deltoid on 06/04/04.  There was not report of an adverse event occurring after the receipt of these vaccinations.
A few weeks after receiving the vaccine, I started losing weight rapidly. Excessive thirst and headaches followed. From May 2021 to September 2021, I lost approximately 55 lbs. Went to get checked out. Blood test given, then I was sent to the ER. ER conducted another blood test and gave diagnosis of diabetes with a fasting blood glucose level of 494. A1C >15.5 . Official type 2 diabetes diagnosis on September  9, 2021 after testing positive for antibodies.
large red spot with spots of degrading skin on the left deltoid; large red spot with spots of degrading skin on the left deltoid; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH MACULAR (non-serious), SKIN DISORDER (non-serious) all with onset 16Nov2022, outcome "unknown" and all described as "large red spot with spots of degrading skin on the left deltoid".  Additional information: On 16Nov2022, the patient had large red spot with spots of degrading skin on the left deltoid. Event took place after use of product.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Exactly half an hour after getting my second dose I started experiencing a tightness/cramping in my right leg and foot.This pain didn?t alleviate within 48 hours and made it difficult to walk at times.Two weeks from the second shot and I still have occasional cramping and knee weakness that wasn?t present prior to getting my shot .
pt recvd vax OCT94 & exp ascending paralysis & was hospitalized w/GBS from 1NOV94 until 19MAY95;event considered disabling;during hospitalization exp blood clot & a pulmonary embolus (MAR95);
Flushing/sweating, dizziness, nausea. Stable, released from vaccination site.
No adverse effects reported.; an unspecified number of patients received improperly stored dose of RECOMBIVAX, GARDASIL 9, MMRII, or PROQUAD; The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify.  Follow-up information has been received from the practice manager on 18-SEP-2018.  This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided.       On 24-APR-2018, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (recombinant Human albumin) (strength and route were unknown) (lot#  N020620 and expiration date 22-JAN-2019) for prophylaxis (Incorrect product storage). The sterile diluent (MERCK STERILE DILUENT) was properly stored. No adverse event was reported.  The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001959:
After receiving the Covid Vaccine, Pt was waiting in a chair as advised by our pharmacists to make sure he had no adverse reactions. About 5 minutes after receiving the vaccine, pt reports he felt dizzy and fainted from the chair falling on the floor. Pharmacist immediately called 911. Pt recovered after a few seconds but pharmacy staff advised him not to move. Paramedics came and took him out in a stretcher.
No symptoms at first. 8 days after, where shot was administered area turned red, warm to touch, itchy, sore when pressure applied and hard. Currently on day 10, still itchy and red. All other symptoms cleared.
Patient had a severe anaphylactic response & was sent to ER in ambulance. Reaction started as hives at injection site. Proceeded to have hives grow in size & all over body. Size tree to silver dollar size. Nose & eyes started watering, coughing & wheezing/change in breathing. Then vomiting & diarrhea. Fluids pouring from every one of her orifices. By the time ambulance arrived, her throat was closing & breathing was slowing. I did report this all to her Dr. after it all happened. Patient was treated at the ER for anaphylaxis.
Since receiving my flu shot I am having severe pain in my right shoulder that is making it difficult to sleep. My range of motion is limited and the pain is sharp.
The patient's past medical history included No adverse event.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced LIMB DISCOMFORT (arm discomfort) and MYALGIA (muscle aches). On 08-Mar-2021, the patient experienced AGEUSIA (losing sense of taste and smell) and ANOSMIA (losing sense of taste and smell). At the time of the report, LIMB DISCOMFORT (arm discomfort), MYALGIA (muscle aches), AGEUSIA (losing sense of taste and smell) and ANOSMIA (losing sense of taste and smell) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment and concomitant medications were reported.
Yesterday, approximately two weeks after my vaccination, I had a dozen grilled shrimp for dinner and had a pretty severe allergic reaction.  I had itching, hives, swelling around one eye and under my chin.  I have never had an allergic reaction to any food before.  I took a benadryl immediately at onset of symptoms and a second one before bed.  It helped control the itching but now even 24 hours later the swelling is just starting to go down.   Obviously I have no idea if this was due to the vaccine or not but it seems very coincidental that this would happen for the first time in my life within two weeks of getting the shot,  I still plan to get the second shot but will avoid shellfish for some time.
This spontaneous report was received from a Registered nurse regarding a 14 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 26-JUN-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot# N004798 with expiration date: 31-OCT-2019 (dosing details and route of administration was not reported) for prophylaxis. No adverse effects were reported. The storage temperature was 47 degrees Fahrenheit to 77 degrees Fahrenheit (49F) and time frame was 14 hours. There was no previous temperature excursion. Digital data logger was involved. No product quality complaint was involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1804USA005153.
Shingles; Skin peeling; Rash/ Cutaneous eruption/ bright red patch; Chest Burning; aching; Headache; stiff neck; This case was reported by a physician via call center representative and described the occurrence of shingles in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Embrel. Concurrent medical conditions included rheumatoid arthritis and immunocompromised (Compromised immune System). Concomitant products included adalimumab (Humira), prednisone, meloxicam (Mobic) and lansoprazole (Prevacid).   In May 2019, the patient received Shingrix. In May 2019, immediately after receiving Shingrix, the patient experienced pain, headache and stiff neck. On 5th June 2019, the patient experienced burning sensation. On 6th June 2019, the patient experienced red rash. On 7th June 2019, the patient experienced shingles and skin peeling. The patient was treated with valaciclovir hydrochloride (Valtrex). In June 2019, the outcome of the pain, headache and stiff neck were recovered/resolved. On an unknown date, the outcome of the shingles and skin peeling were unknown and the outcome of the burning sensation was not recovered/not resolved and the outcome of the red rash was recovering/resolving.   It was unknown if the reporter considered the shingles, pain, headache, stiff neck, burning sensation, red rash and skin peeling to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix vaccine 2 weeks ago, from the date of reporting. The patient was seen by rheumatologist first and then referred to dermatologist. Immediately after vaccination the patient experienced aching, headache, and stiff neck which lasted for about 2 weeks. On 5th June 2019, the patient visited her chiropractor due to stiff neck. Later that evening, the patient felt like burning fire on her chest. On next day morning, she woke up with bright red patch from midline on her chest to left breast to mid neck. Along with circular rash below both medial breasts. The patient came to dermatologist on 7th June 2019. The dermatologist stated it was perfect presentation of dermatomal distribution of t5 and t6. The dermatologist diagnosed the condition as Shingles, and has put the patient on Valtrex 1 tablet three times daily for 2 weeks. The cutaneous eruption had improved, but the burning was present, at the time of reporting.  The patient's rash underneath the breast was peeling off like a severe sunburn. The peeling rash stopped at middle of chest to spinal area, and to the back and stopped at mid line below the nipple and umbilicus. There were no discreet vesicles present. No further details were provided.
No additional AE information provided. No PQC.; HCP states that a 19-year-old patient received a pediatric dose of VAQTA today, instead of the adult dose; Dose administered: 0.5 mL; This spontaneous report was received from a registered medical assistant referring to a 19-years-old patient of unknown gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided.   On 28-NOV-2022 (also reported as today), the patient was vaccinated with a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, dose of 0.5 mL, lot number: W007375, expiration date: 16-JAN-2023 (dose number, route of administration and anatomical location were not reported) for prophylaxis (product administered to patient of inappropriate age, incorrect dose administered). No additional adverse event (AE) information was provided (no adverse event).
After receiving my first dose of the covid 19 vaccine, I waited 20 minutes before leaving. As I walked back to my car I started to feel off and like something was wrong. By the time I got to my car, I was very dizzy and felt as though I were going to pass out. I immediately called my husband and advised him of my location and general surrounding in the event I did pass out while on the phone. After sitting in my car for a few minutes I started to feel slightly better, but not good. So I decided to walk back to the clinic building and get looked at to err on the side of caution. I walked about 10 parking spaces and then almost collapsed, so I laid on the ground and yelled to someone passing by to go get help. Someone comes and gets me and they take me over to the EMTs inside the clinic where they did a basic checks and everything came back ok. We decided to go over the the ER for further testing which revealed no answers as to why I was feeling this way. I was sent home 4 hours in the emergency room, still presenting with dizziness and lightheadedness. It took about 8-10 days before I was functioning at full capacity again. However since the vaccine intermittently throughout the day, when I go from sitting/laying to standing I black out and sometimes collapse or have to sit down so I don't fall. I discussed this with my PCP regarding the issues and counseling with them. They advised I see the cardiologist for further testing and consultation. I was finally able to see my cardiologist yesterday 5/11/21 (his schedule fills very fast). After  counseling with him and discussing all the events leading up to my visit with him. It was his professional opinion that my problems and symptoms were a direct cause of the vaccine and that I should absolutely not receive the 2nd dose of the vaccine.
Arm very sore and red; swollen and hot to touch; hurt on inside of arm all way to elbow.  felt at know at site.
pt recv vax 15NOV95 & exp severe non-pruritic gen macular rash;inj site swelling;lesion were erythematous, irregular & approx 1cm in diameter;adenopathy ax;skin biopsy revealed extensive hypersensitivity vasculitis;
Morning of vaccine took 10 mg of Zyrtec and 20 mg Pepcid. At 2:45 pm took 20 mg Zyrtec and 20 mg of Pepcid. This was per my allergist recommendation.  Vaccine received at 4:15 pm . 45 minutes after receiving vaccine my tongue began to tingle. It then began to swell. Within next 20 minutes I had facial swelling and redness on my checks. I had no problems breathing or swallowing. Took 50 mg of Benadryl. Did not improve and took 20 mg of prednisone. Swelling stopped increasing. Anything I put in my mouth the taste was intensified. Pop tasted flat. Took 10 mg Zyrtec and 20 mg Pepcid.  By 11 pm the redness was gone in face. Swelling was going down in face. Tongue was still swollen. At midnight took 25 mg of Benadryl. At 6:45 am when I woke I had no more swelling but my tongue is still tingling. All day my tongue hurt and as of 7:20 pm it still hurts at the tip. During the day I had a headache. Arm pain.  Spoke with allergist and advised to continue the increase dose of Zyrtec Thursday.
SICKNESS; MUSCLE STIFFNESS/NECK STIFFNESS; SHOOTING PAIN BESIDE THE NECK AND FACE; SORE ARM; FEVER; HEADACHE; TIREDNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 02-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 02-MAY-2021, the subject experienced sickness. On 02-MAY-2021, the subject experienced muscle stiffness/neck stiffness. On 02-MAY-2021, the subject experienced shooting pain beside the neck and face. On 02-MAY-2021, the subject experienced sore arm. On 02-MAY-2021, the subject experienced fever. On 02-MAY-2021, the subject experienced headache. On 02-MAY-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sore arm, shooting pain beside the neck and face, fever, muscle stiffness/neck stiffness, headache, and sickness, and the outcome of tiredness was not reported. This report was non-serious.
Pt. developed acute cough and wheeze within 5 minutes of vaccines. Treated with albuterol x 2. Was sent to ER. Lip swelling developed in ER, treated with BENADRYL.
INJECTION SITE PAIN; SWELLING AT INJECTION SITE; This spontaneous report received from a patient concerned a 43 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included unspecified allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021 in right arm for prophylactic vaccination. No concomitant medications were reported. On 23-MAR-2021, the subject experienced injection site pain. On 23-MAR-2021, the subject experienced swelling at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from injection site pain, and had not recovered from swelling at injection site. This report was non-serious.
10/30/21-The current episode started 2 days ago. The problem has been gradually worsening. The cough is productive of sputum. The maximum temperature recorded prior to her arrival was 100 to 100.9 F (TODAY AT ICC). The fever has been present for less than 1 day. Associated symptoms include rhinorrhea, sore throat and myalgias. Pertinent negatives include no chest pain, no chills, no sweats, no weight loss, no ear congestion, no ear pain, no headaches, no shortness of breath, no wheezing and no eye redness  Review of Symptoms:   Review of Systems  Constitutional: Negative for activity change, chills and weight loss.  HENT: Positive for rhinorrhea, sinus pressure and sore throat. Negative for ear pain.       Eyes: Negative for redness.  Respiratory: Positive for cough. Negative for shortness of breath and wheezing.   Cardiovascular: Negative for chest pain.  Musculoskeletal: Positive for myalgias.  Neurological: Negative for speech difficulty, numbness and headaches.
Pain in the lungs or kidney; Pain in the lungs or kidney; without strength; tired; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (Pain in the lungs or kidney), RENAL PAIN (Pain in the lungs or kidney), ASTHENIA (without strength) and FATIGUE (tired) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 038A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Had COVID in 2020).   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PULMONARY PAIN (Pain in the lungs or kidney), RENAL PAIN (Pain in the lungs or kidney), ASTHENIA (without strength) and FATIGUE (tired). At the time of the report, PULMONARY PAIN (Pain in the lungs or kidney), RENAL PAIN (Pain in the lungs or kidney), ASTHENIA (without strength) and FATIGUE (tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Had COVID in 2020.         No concomitant medications were mentioned.  The patient's symptoms started a week after the second dose and. The patient mentioned that after the first dose felt something on the arm, but that was all.  No treatment details were reported.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments    This case was linked to MOD-2021-213314 (Patient Link).
Initial report was received from a physician on 21 March 2008. A physician, who is a neurologist, reported that a patient (identifiers not provided) may have experienced a possible neurological reaction after receipt of ADACEL. No further information was provided at the time of the report.
Information has been received from a nurse referring to an unspecified number of patients (age and gender unknown). The patients' pertinent medical history, drug reactions/allergies and concomitant medication were not provided. On unspecified dates the patients might have been vaccinated with an improperly stored dose of M-M-R II rHA (lot # M039913, expiration date 26-SEP-2018, M045401, expiration date 14-NOV-2018; dose and route were unknown) for prophylaxis.    The lot numbers and expiration dates of the sterile diluent used for reconstitution of the M-M-R II were unknown. No adverse effects were reported. The vaccines were stored under 47 Fahrenheit to 77 Fahrenheit (52 Fahrenheit) for 52 hours. There was no previous temperature excursion. Data logger was not involved.
I received my first dose of Pfizer COVID-19 vaccine on 07/21/2021.  The next day, 07/22/2021 I woke up at approx 0600 with tenderness to my injection site on my left deltoid.  I had radiating pain to my left shoulder into my neck.  This pain triggered a migraine with nausea.  The left arm pain persisted for approximately 3 days after injection. At or around 07/27/2021, I developed breast tenderness, increased appetite, irritability, lower abdominal and back cramping.  The breast tenderness, increased appetite, and irritability persisted until 08/27/2021.  I had visited my PCP and was offered testing but declined to see if the symptoms would reside on their own, in which they did.  I received my second dose of Pfizer COVID-19 vaccine on 08/11/2021.  Once again on the following day, I had tenderness along with bruising to the injection site on my left deltoid.  I also awoke with a low grade temperature of 99.9 orally, body aches, headache, sore throat, and fatigue.  I was not able to go to work that day.  Symptoms started to subside throughout the day.
After the shot I was nauseated, my heart was pounding and racing. After it continue I went to the ER. Body aches, chills, low grade fever.
Swelling, redness, pain at injection site 7 days after injection. No side effects between date of injection (1/7/21) and date of symptom onset (1/14/21). Symptoms are mild to moderate covering the entire upper left arm and shoulder.
wound on the bottom of his foot; This spontaneous case was reported by a consumer and describes the occurrence of LIMB INJURY (wound on the bottom of his foot) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included Peripheral arterial disease (chronic circulation problems in his legs). Concurrent medical conditions included Wound (wound on the bottom of foot).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB INJURY (wound on the bottom of his foot). At the time of the report, LIMB INJURY (wound on the bottom of his foot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications are provided. Patient had no changes in his foot conditions due to vaccine.  Treatment medication includes; Amoxycillin, Doxycycline and Levofloxacin Patients print out for these pharmaceuticals told him not to take any Viral Vaccine along with treatment medications. Second dose of vaccine is due on 14APR2021
Heavy itching at site of injection and down the arm for approximately 2 weeks Used itch cream and Claritin tablet every few days